DC
GOSS icon

Diametric Capital’s Gossamer Bio GOSS Stock Holding History

Diametric Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-89,382
Closed -$110K – 427
2025
Q2 		$110K Sell
89,382
-6,731
-7% -$7.34K 0.06% 292
2025
Q1 		$106K Sell
96,113
-127,657
-57% -$148K 0.13% 167
2024
Q4 		$202K Sell
223,770
-63,489
-22% -$54.4K 0.14% 237
2024
Q3 		$283K Buy
+287,259
New +$276K 0.14% 221

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Diametric Capital's GOSS Position: Q3 2025 in Review

Diametric Capital sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 89,382 shares — an estimated $110K sold.

Diametric Capital first reported a position in GOSS in Q3 2024 and held it in 4 quarters. The position peaked at $283K in Q3 2024. 164 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • Diametric Capital reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
  • Diametric Capital sold 89,382 Gossamer Bio shares in Q3 2025, an estimated $110K.
  • Diametric Capital first reported a position in Gossamer Bio in Q3 2024 and held it in 4 quarters.
  • Diametric Capital's Gossamer Bio position peaked at $283K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on Diametric Capital's 13F filing for Q3 2025, filed 13 Nov 2025.